Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dan Strat"'
Autor:
Nicolas Poupore, Dan Strat, Tristan Mackey, Katherine Brown, Ashley Snell, Thomas I. Nathaniel
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-14 (2020)
Abstract Background Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (r
Externí odkaz:
https://doaj.org/article/528e5bf663204fa992dd67637baefa9d
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Acute ischemic stroke attack with and without a recent TIA may differ in clinical risk factors, and this may affect treatment outcomes following thrombolytic therapy. We examined whether the odds of exclusion or inclusion for thro
Externí odkaz:
https://doaj.org/article/da798b88805f4c7c9cceeee4d32606f2
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Background: Specific clinical risk factors linked to transient ischemic attack (TIA) could affect functional ambulatory outcome following thrombolytic therapy in patients having ischemic stroke with a prior TIA (TIA-ischemic stroke). This issue was i
Externí odkaz:
https://doaj.org/article/59204895ba7f46fc8f7d38902e2f12cf
Autor:
Ephraim A. Ansa‐Addo, Paras Pathak, Maria V. McCrossan, Izadora Volpato Rossi, Mahamed Abdullahi, Dan Stratton, Sigrun Lange, Marcel I. Ramirez, Jameel M. Inal
Publikováno v:
Journal of Extracellular Vesicles, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract During cell invasion, large Extracellular Vesicle (lEV) release from host cells was dose‐dependently triggered by Trypanosoma cruzi metacyclic trypomastigotes (Mtr). This lEV release was inhibited when IP3‐mediated Ca2+ exit from the ER
Externí odkaz:
https://doaj.org/article/3fd58d97f3924d10b24848b3ac203071
Autor:
Katherine Brown, Thomas I. Nathaniel, Nicolas Poupore, Dan Strat, Tristan Mackey, Ashley Snell
Publikováno v:
Neurology and Clinical Neuroscience. 8:298-308
Autor:
Ashley Snell, Katherine Brown, Nicolas Poupore, Tristan Mackey, Dan Strat, Thomas I. Nathaniel
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-14 (2020)
Lipids in Health and Disease
Lipids in Health and Disease
BackgroundSpecific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) thera
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Background: Specific clinical risk factors linked to transient ischemic attack (TIA) could affect functional ambulatory outcome following thrombolytic therapy in patients having ischemic stroke with a prior TIA (TIA-ischemic stroke). This issue was i
Background Specific clinical risk factors may contribute to worsening or improving neurological functions in an acute ischemic stroke (AIS) patient pre-treated with a cholesterol reducer with a subsequent recombinant tissue plasminogen activator (rtP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9f9b02840d30d06ddf5ac32d6187a80
https://doi.org/10.21203/rs.2.20629/v1
https://doi.org/10.21203/rs.2.20629/v1
Publikováno v:
Journal of Vascular and Interventional Radiology. 33:215
Background Acute ischemic stroke attack with and without a recent TIA within or less than 24 hours may differ in clinical risk factors, and this may affect treatment outcomes following thrombolytic therapy. We examined whether the odds of exclusion o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd14b797d59e75fdcd1f7612b12e5dc
https://doi.org/10.21203/rs.2.17137/v1
https://doi.org/10.21203/rs.2.17137/v1